Insider Selling: PureTech Health plc (LON:PRTC) Insider Sells £582,745 in Stock

PureTech Health plc (LON:PRTC) insider Robert Langer sold 233,098 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of GBX 250 ($3.17), for a total value of £582,745 ($739,242.67).

PureTech Health Stock Performance

Shares of LON PRTC opened at GBX 183 ($2.32) on Friday. PureTech Health plc has a 12 month low of GBX 139 ($1.76) and a 12 month high of GBX 238.50 ($3.03). The company has a market cap of £494.85 million, a P/E ratio of -963.16 and a beta of 0.93. The business’s 50 day moving average is GBX 218.88 and its two-hundred day moving average is GBX 204.28. The company has a quick ratio of 2.51, a current ratio of 6.76 and a debt-to-equity ratio of 29.57.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.